-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
The importance of technology in global health trials
Trudie Lang
Editorial: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Pharmacotherapy of deep-venous thrombosis: current status and future perspective
Alessandro Squizzato, Elena Rancan, Francesco Dentali
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation